Beginning this month, the following Tilray Medical products are approved for therapeutic use in Italy and available for distribution through pharmacies across Italy: ...

About the Phase 3 C-BEYOND and C-FORWARD Trials in Adults with Chronic HCV ...

Vazkepa® supported by strong clinical data package and expected to contribute to Specialty & Primary Care growth in coming years ...

OTTAWA, June 24, 2025 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is pleased to announce the appointment of Dr. Mark Kirchhof as CDA President, effective June 19, 2025.

The Strategic Committee engaged BroadOak Capital Partners as financial advisor and BakerHostetler LLP as legal counsel to assist in evaluating the transaction. Further details of the transaction are ...

The trial is a multi-centre, open-label Phase 2 clinical trial testing the safety and efficacy of Acoustic Cluster Therapy (ACT ®) in combination with standard of care (modified FOLFIRINOX ...

Fueled by a 198% surge in Q4 device sales revenue and a 200% increase in shipments, Hapbee’s revitalized marketing strategy, expanded retail footprint, luxury spa partnerships, and high-profile Board ...

Camfil, a global leader in clean air solutions, shares its tailored solutions designed specifically to address critical ...

Stacey Rusch is an entrepreneur, philanthropist, and personality. With a career spanning media, she turned to star on Bravo’s ...

Onco360 is grateful for the opportunity to partner with the team at Deciphera and become a specialty pharmacy provider for ROMVIMZA,” said Benito Fernandez, Chief Commercial Officer. “This addition ...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in ...